DPW
HRMY icon

DiNuzzo Private Wealth’s Harmony Biosciences HRMY Stock Holding History

DiNuzzo Private Wealth’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4
Closed -$148 – 1385
2025
Q3 		$148 Hold
4
– – ﹤0.01% 1285
2025
Q2 		$127 Hold
4
– – ﹤0.01% 1286
2025
Q1 		$133 Buy
4
+1
+33% +$36 ﹤0.01% 1277
2024
Q4 		$104 Sell
3
-2
-40% -$69 ﹤0.01% 1335
2024
Q3 		$200 Buy
5
+2
+67% +$70 ﹤0.01% 1296
2024
Q2 		$91 Buy
3
+1
+50% +$30 ﹤0.01% 1352
2024
Q1 		$68 Sell
2
-1
-33% -$32 ﹤0.01% 1315
2023
Q4 		$97 Buy
+3
New +$84 ﹤0.01% 1324

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

DiNuzzo Private Wealth's HRMY Position: Q4 2025 in Review

DiNuzzo Private Wealth sold out of Harmony Biosciences (HRMY) in Q4 2025, closing a stake of 4 shares — an estimated $148 sold.

DiNuzzo Private Wealth first reported a position in HRMY in Q4 2023 and held it in 8 quarters. The position peaked at $200 in Q3 2024. 323 funds tracked by Wall St. Rank hold HRMY as of Q4 2025.

  • DiNuzzo Private Wealth reported no remaining Harmony Biosciences position as of Q4 2025 after selling out during the quarter.
  • DiNuzzo Private Wealth sold 4 Harmony Biosciences shares in Q4 2025, an estimated $148.
  • DiNuzzo Private Wealth first reported a position in Harmony Biosciences in Q4 2023 and held it in 8 quarters.
  • DiNuzzo Private Wealth's Harmony Biosciences position peaked at $200 in Q3 2024.
  • 323 funds tracked by Wall St. Rank held Harmony Biosciences as of Q4 2025.

Based on DiNuzzo Private Wealth's 13F filing for Q4 2025, filed 16 Jan 2026.